BamSEC and AlphaSense Join Forces
Learn More

Phathom Pharmaceuticals Inc. – Articles of Incorporation

NASDAQ: PHAT    
Share price (3/30/26): $10.53    
Market cap (3/30/26): $830 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 40 pages Amended and Restated Bylaws of Phathom Pharmaceuticals, Inc. (A Delaware Corporation) as Amended and Restated September 22, 2020december 13, 2023
12/34/56
EX-3.1
from 8-K 37 pages Amended and Restated Bylaws of Phathom Pharmaceuticals, Inc. (A Delaware Corporation) as Amended and Restated December 13, 2023
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Phathom Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 37 pages Amended and Restated Bylaws of Phathom Pharmaceuticals, Inc. (A Delaware Corporation) as Amended and Restated September 22, 2020
12/34/56
EX-3.2
from 8-K 37 pages Amended and Restated Bylaws of Phathom Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 7 pages Amended and Restated Certificate of Incorporation of Phathom Pharmaceuticals, Inc
12/34/56
EX-3.1
from S-1/A 7 pages Amended and Restated Certificate of Incorporation of Phathom Pharmaceuticals, Inc
12/34/56
EX-3.4
from S-1 37 pages Amended and Restated Bylaws of Phathom Pharmaceuticals, Inc
12/34/56
EX-3.3
from S-1 7 pages Amended and Restated Certificate of Incorporation of Phathom Pharmaceuticals, Inc
12/34/56
EX-3.2
from S-1 25 pages Bylaws of Phathom Pharmaceuticals, Inc. (A Delaware Corporation) Adopted as of January 30, 2018 Amended as of May 7, 2019
12/34/56
EX-3.1
from S-1 4 pages Amended and Restated Certificate of Incorporation of Phathom Pharmaceuticals, Inc
12/34/56
EX-3.2
from DRS 25 pages Bylaws of Phathom Pharmaceuticals, Inc. (A Delaware Corporation) Adopted as of January 30, 2018 Amended as of May 7, 2019
12/34/56
EX-3.1
from DRS 4 pages Amended and Restated Certificate of Incorporation of Phathom Pharmaceuticals, Inc
12/34/56